Natco Pharma has informed that the meeting of the Board of Directors of the Company is scheduled to be held on August 12, 2020, to consider the following items of businesses and related matters: to consider Un-audited Financial Results for the quarter ended June 30, 2020; to consider interim dividend, if any for the financial year 2020-21. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, Trading window for dealing in the securities of the Company by the Employee(s) / Director(s) and their immediate relatives will be closed from August 04, 2020 to August 14, 2020. Trading window will be opened on August 17, 2020.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: